Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4094 results

Sort By:

Interaction Between Early Trauma and Odor-induced Dopamine Release

Study ID: NCT06284382
Start Date: 2025-06-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

High score at Childhood Trauma Questionnaire.

Low score at Childhood Trauma Questionnaire.

Sponsor

Le Vinatier Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Study ID: NCT06887348
Start Date: 2025-06
End Date: 2035-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Observational study with no interventions

Sponsor

Replimune Inc.

Source: clinicaltrials.gov

Share:
Add to list

Targeted Transcranial Magnetic Stimulation to Improve Language and Speech in Patients With Primary Progressive Aphasia

Study ID: NCT06921265
Start Date: 2025-07-15
End Date: 2029-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Training with Speech Language Therapy

Standard rTMS

Targeted rTMS

Standard rTMS (first cycle)

Standard rTMS (second cycle)

Targeted rTMS (first cycle)

Targeted rTMS (second cycle)

Sponsor

IRCCS San Raffaele

Source: clinicaltrials.gov

Share:
Add to list

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

Study ID: NCT06853665
Start Date: 2025-05-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

196

Intervention / Treatment

Adderall XR (mixed salts amphetamine)

Placebo

Sponsor

Gagan Joshi

Source: clinicaltrials.gov

Share:
Add to list

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Study ID: NCT06406465
Start Date: 2025-04-23
End Date: 2028-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Whiteness

Cisplatin

Etoposide

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Immune Cell Populations in the Endometrium

Study ID: NCT06826365
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Percentage distribution of immune system cells in peripheral blood

Percentage distribution of immune system cells in endometrium

Sponsor

Year of the Year.

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Oscillation on Postoperative Pulmonary Complications After Elective Postcardiac Surgery

Study ID: NCT06902220
Start Date: 2025-09-01
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

470

Intervention / Treatment

continuous high-frequency oscillation therapy

Sponsor

Southeast University, China

Source: clinicaltrials.gov

Share:
Add to list

BC179 Against Alcohol-Induced Damage

Study ID: NCT06899620
Start Date: 2025-05-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Probiotic group

Placebo group

Sponsor

Wecare Probiotics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Ablative Radioembolization of Renal Cell Carcinoma Trial

Study ID: NCT06642220
Start Date: 2025-05-15
End Date: 2032-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

Y-90 Selective Internal Radiation Therapy (SIRT)

Sponsor

Derek W. Cool

Source: clinicaltrials.gov

Share:
Add to list

Effect of Predictive Model on ED Physician Assessments of Patient Disposition

Study ID: NCT06434220
Start Date: 2026-05-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Baseline model

Fairness-aware model

Sponsor

Boston Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list